Entering the national phase of your Patent Cooperation Treaty (PCT) application in Australia and New Zealand can lead to IP protection in these valuable markets. Baxter IP, a premier boutique Australian intellectual property law firm guides foreign associates and companies through the PCT national phase entry process in Australia and New Zealand.
Why Choose Australia and New Zealand for Patent Protection?
International Market Leader: Australia is home to internationally leading companies in mining (e.g. BHP, Rio Tinto), construction (CSR) and medical devices (ResMed, Cochlear, Medtronic). In recent years biotech, defense and climate-tech industries have also seen significant growth. New Zealand is home to internationally leading companies in agritech (e.g. Gallagher Group, LIC), dairy innovation (Fonterra, A2 Milk) and biotechnology (Pacific Edge, BLIS Technologies). In recent years digital technology, clean energy and pharmaceutical research industries have also seen significant growth.Strategic Market Access: Securing patents in these markets opens doors to thriving pilot markets and wealthy consumers with a high demand for innovative technologies and products.Gateway to Asia-Pacific: Establishing patent rights in Australia and New Zealand positions companies advantageously for expansion into the broader Asia-Pacific region.Understanding National Phase Entry Deadlines
Australia: 31 months from the earliest priority date.New Zealand: 31 months Securing patents in these markets opens doors to thriving pilot markets and wealthy consumers with a high demand for innovative technologies and products.Missing these deadlines will result in the loss of patent rights in these jurisdictions.
